<- Go Home

LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Market Cap

$81.0M

Volume

75.4K

Cash and Equivalents

$13.6M

EBITDA

-$16.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$29.1M

Profit Margin

48.34%

52 Week High

$12.94

52 Week Low

$4.95

Dividend

N/A

Price / Book Value

5.43

Price / Earnings

12.42

Price / Tangible Book Value

7.96

Enterprise Value

$83.6M

Enterprise Value / EBITDA

-5.36

Operating Income

-$20.9M

Return on Equity

357.30%

Return on Assets

-18.66

Cash and Short Term Investments

$13.6M

Debt

$2.4M

Equity

$28.7M

Revenue

$60.3M

Unlevered FCF

-$24.4M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches